다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Aileron Therapeutics Inc (ALRN)
Aileron Therapeutics Inc (ALRN) 뉴스

ALRN

Aileron Therapeutics (ALRN)

Aileron Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALRN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/08/23	05:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/08/23	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/08/23	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/08/22	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/08/20	05:05	PR Newswire (US)	Aileron Therapeutics to Present at the 8th Annual IPF Summit	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/08/15	07:05	PR Newswire (US)	Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/08/15	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/08/15	06:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/07/30	21:00	PR Newswire (US)	Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/07/27	05:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/07/27	05:33	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/07/27	05:29	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/07/09	21:41	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/07/09	21:36	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/07/09	21:30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/07/01	21:00	PR Newswire (US)	Aileron Therapeutics to be Included in the Russell Microcap® Index	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/06/05	19:58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/17	06:19	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/17	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/16	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/16	06:13	GlobeNewswire Inc.	Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/16	06:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/07	05:05	GlobeNewswire Inc.	Aileron Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/04	05:05	GlobeNewswire Inc.	Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/01	21:45	GlobeNewswire Inc.	Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/01	21:30	GlobeNewswire Inc.	Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/04/16	06:20	GlobeNewswire Inc.	Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/03/12	21:00	GlobeNewswire Inc.	Aileron Therapeutics Announces CEO Transition	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/03/07	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/02/29	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc

검색 관련기사 보기:NASDAQ:ALRN

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Sterling

American Express

Gold vs US Dollar

Financial Select Sector

Health Care Select Sector

JP Morgan Chase

Deutsche Telekom (QX)

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관